Combination of CD19 and CD22 CAR T-Cell Therapy in Relapsed B-Cell ALL After Allogeneic Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination of CD19 and CD22 CAR-T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia After Allogeneic Transplantation
Am. J. Hematol 2021 Mar 16;[EPub Ahead of Print], S Liu, B Deng, Z Yin, Y Lin, L An, D Liu, J Pan, X Yu, B Chen, T Wu, AH Chang, C TongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.